Day: February 11, 2015

One of the FDA’s advisory committees has circled March 17 on the calendar for its review of Celltrion‘s Remsima, a biosimilar of Johnson & Johnson’s ($JNJ) Remicade that is now in line to become the second knockoff to reach the… Continue Reading →

Drug companies are a bit like high-school boyfriends,” Oliver said. “They’re much more concerned with getting inside you than being effective once they’re in there. Oliver pointed out pharmaceutical companies spent more than $24 billion marketing to doctors in 2012.… Continue Reading →